Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies

K. S. Sridhar, A. Krishan, T. S.A. Samy, A. Sauerteig, L. L. Wellham, G. McPhee, R. C. Duncan, S. Y. Anac, B. Ardalan, P. W. Benedetto

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds